Is there anybody evidence that says due to transfat and refined oil - a person is more susceptible to insulin resistance ?
Reading Document
Medical Text Search
trans fat insulin resistance mechanism
Medical Text Search
refined vegetable oil dietary fat insulin resistance type 2 diabetes
GradeResponse
GradeResponse
Here is a thorough synthesis of the evidence:
Trans Fats, Refined Oils & Insulin Resistance — What the Evidence Says
Trans Fats
The evidence on trans fats and insulin resistance specifically is more nuanced than commonly believed:
- A meta-analysis of 7 randomized controlled trials (RCTs) found that increased trans fat intake did not result in statistically significant changes in glucose, insulin, or triglyceride concentrations (Nutrition Therapy for Adults With Diabetes or Prediabetes, p. 14).
- However, trans fats did raise total cholesterol and LDL-C while lowering HDL-C — worsening the overall cardiometabolic risk profile.
- Trans fats are strongly associated with all-cause mortality, total coronary heart disease (CHD), and CHD mortality — so their harm is well-documented, just the direct insulin-resistance pathway is less clear-cut in RCT data.
Mechanistic evidence (from broader literature):
- Trans fats (particularly industrial partially hydrogenated oils) are thought to impair insulin signaling by:
- Incorporating into cell membrane phospholipids, altering membrane fluidity and insulin receptor function
- Promoting pro-inflammatory cytokine release (TNF-α, IL-6), which interferes with insulin signaling cascades (IRS-1/PI3K pathway)
- Increasing visceral adiposity, a key driver of insulin resistance
- Observational studies (notably the Nurses' Health Study) have linked higher trans fat intake to elevated risk of type 2 diabetes, even after adjusting for other dietary factors.
Refined / Processed Oils (High in Omega-6 Linoleic Acid)
The evidence here is more about the type of fat consumed:
| Fat Type | Effect on Insulin Resistance |
|---|---|
| Polyunsaturated fats (PUFA) — including refined vegetable oils | Associated with lower risk of T2DM in large epidemiologic studies |
| Omega-3 PUFAs (EPA/DHA) | Improved postprandial glycemia, insulin secretion, and endothelial function in RCTs (p. 4) |
| Trans fats | Neutral in RCT glucose/insulin metrics but harmful to lipid profile and CVD risk |
| Saturated fats | Broadly associated with worsened insulin sensitivity via TLR4-mediated inflammation |
- Large epidemiologic studies show that consumption of polyunsaturated fatty acids (PUFAs) or biomarkers of PUFAs are associated with lower risk of type 2 diabetes (Nutrition Therapy for Adults With Diabetes or Prediabetes, p. 4).
- Refined oils high in omega-6 (e.g., soybean, corn, sunflower oil) are not inherently insulin-resistance-promoting — the concern is a high omega-6:omega-3 ratio in the modern diet, which promotes a low-grade inflammatory state that can impair insulin signaling over time.
- Oxidized lipids from repeatedly heated refined oils (common in processed/fried foods) do have evidence of promoting oxidative stress and inflammation — indirect pathways to insulin resistance.
Bottom Line
| Claim | Evidence Strength |
|---|---|
| Trans fats directly cause insulin resistance | Weak (RCT data inconclusive for glucose/insulin outcomes) |
| Trans fats increase CVD risk and all-cause mortality | Strong |
| Trans fat intake associated with T2DM risk (observational) | Moderate |
| Refined oils (PUFAs) worsen insulin resistance | Not supported — PUFAs are generally protective |
| High omega-6:omega-3 ratio → pro-inflammatory → insulin resistance | Plausible/moderate (mechanistic + epidemiologic) |
| Oxidized/repeatedly heated oils → metabolic harm | Emerging evidence |
The strongest evidence links trans fats to cardiovascular disease rather than to insulin resistance as an independent pathway. That said, any dietary pattern rich in ultra-processed foods (which typically contain both trans fats and refined oils alongside refined carbohydrates) robustly predicts insulin resistance — making it difficult to isolate individual fat types as the sole culprit.
A video showcases that diabetes happens because sugar cannot enter the cells S
Medical Text Search
insulin resistance mechanism glucose uptake cells type 2 diabetes pathophysiology
GradeResponse
This is a partial but oversimplified explanation. Here's what's actually happening:
What the Video Got Right (and Wrong)
The Simplified Version (What the Video Says)
"Sugar cannot enter the cells."
This is directionally correct but strips out critical nuance. It describes the end result, not the actual mechanism.
The Full Pathophysiology (Harrison's, p. 11290)
Type 2 diabetes is not a single defect — it involves multiple simultaneous failures:
1. Insulin Resistance (the core problem)
- Cells (muscle, fat, liver) stop responding normally to insulin
- Insulin is the "key" that unlocks glucose entry into cells via GLUT4 transporters
- When cells become insulin-resistant, the key no longer fits well — glucose stays in the bloodstream
- So yes, sugar struggles to enter cells — but the reason is resistance to insulin signaling, not an absence of insulin
2. Compensatory Hyperinsulinemia (early phase)
- The pancreatic beta cells detect high blood glucose and overwork to produce more insulin
- At this stage, blood sugar may still be near-normal despite insulin resistance
- The person is diabetic in mechanism but not yet by lab values
3. Beta Cell Exhaustion (later phase)
- Over time, the beta cells cannot sustain the extra output
- Insulin secretion drops
- Blood glucose rises — now diagnosable as T2DM
4. Excessive Hepatic Glucose Production
- The liver keeps dumping glucose into the blood even when blood sugar is already high
- Normally, insulin tells the liver to stop — but insulin resistance means the liver ignores that signal
5. Abnormal Fat Metabolism + Inflammation
- Visceral fat releases free fatty acids and pro-inflammatory cytokines (TNF-α, IL-6)
- These directly worsen insulin receptor signaling
- >80% of T2DM patients are obese, particularly with central/visceral fat
A Better Mental Model
Insulin resistance
↓
Beta cells overcompensate (hyperinsulinemia)
↓
Beta cells fatigue and fail
↓
Insulin drops + liver overproduces glucose
↓
Glucose cannot enter cells effectively
↓
Hyperglycemia → Type 2 Diabetes
Key Takeaway
The video's claim — "sugar can't enter cells" — describes one downstream consequence of insulin resistance, not the cause. It misses:
- Why glucose can't enter (faulty insulin signaling)
- The role of the liver in overproducing glucose
- The progressive beta cell failure that defines T2DM's natural history
- The inflammatory and metabolic drivers (visceral fat, free fatty acids)
It's a common simplification used in health content, but it can mislead people into thinking the fix is simply "getting sugar into cells" — when the actual intervention targets insulin sensitivity at a systemic level.
This is a shared conversation. Sign in to Orris to start your own chat.